Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Merger agrmnt [a]
Quarterly results
CC transcript
Inv. presentation
Director departure
Appointed director
AMICUS THERAPEUTICS, INC. (FOLD) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 4,444 shares @ $11.079, valued at $49.2k
Sold 1,600 shares @ $11.7075, valued at $18.7k
10/04/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,200 shares @ $11.2027, valued at $125.5k
Sold 500 shares @ $12.038, valued at $6k
Exercised 11,700 options to buy @ $2.94, valued at $34.4k
08/23/2023 4 Harford Simon N.R. (CFO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 106,973 shares @ $0
Granted 189,043 options to buy @ $12.62, valued at $2.4M
08/23/2023 3 Harford Simon N.R. (CFO) has filed a Form 3 on AMICUS THERAPEUTICS, INC.
08/21/2023 4 Prout Samantha (Chief Accounting Officer) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 7,432 shares @ $12.77, valued at $94.9k
08/21/2023 4 Castelli Jeff (Chief Development Officer) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 14,560 shares @ $12.77, valued at $185.9k
08/16/2023 4 Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 6,044 shares @ $13.0268, valued at $78.7k
08/11/2023 4 Prout Samantha (Chief Accounting Officer) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 36,909 shares @ $14.0056, valued at $516.9k
Exercised 2,376 options to buy @ $10.04, valued at $23.9k
Exercised 5,040 options to buy @ $9.55, valued at $48.1k
Exercised 10,592 options to buy @ $10.03, valued at $106.2k
Exercised 18,901 options to buy @ $12.11, valued at $228.9k
08/03/2023 4 Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 6,044 shares @ $13.3548, valued at $80.7k
08/03/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 20,000 shares @ $13.3937, valued at $267.9k
Exercised 11,700 options to buy @ $2.94, valued at $34.4k
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2023 4 Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 6,044 shares @ $12.3107, valued at $74.4k
07/06/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,700 shares @ $12.3091, valued at $144k
Exercised 11,700 options to buy @ $2.94, valued at $34.4k
06/12/2023 4 RAAB MICHAEL (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 8,584 shares @ $0
Granted 30,474 options to buy @ $12.62, valued at $384.6k
06/12/2023 4 MCGLYNN MARGARET G (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 8,584 shares @ $0
Granted 30,474 options to buy @ $12.62, valued at $384.6k
06/12/2023 4 Kelly Michael Aaron (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 8,584 shares @ $0
Granted 30,474 options to buy @ $12.62, valued at $384.6k
06/12/2023 4 Bleil Lynn Dorsey (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 8,584 shares @ $0
Granted 30,474 options to buy @ $12.62, valued at $384.6k
06/12/2023 4 ROBERTS EIRY (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 8,584 shares @ $0
Granted 30,474 options to buy @ $12.62, valued at $384.6k
06/12/2023 4 SBLENDORIO GLENN (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 8,584 shares @ $0
Granted 30,474 options to buy @ $12.62, valued at $384.6k
06/12/2023 4 WHITMAN BURKE W (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 8,584 shares @ $0
Granted 30,474 options to buy @ $12.62, valued at $384.6k
06/12/2023 4 WHEELER CRAIG A (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 8,584 shares @ $0
Granted 30,474 options to buy @ $12.62, valued at $384.6k
06/08/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 8,300 shares @ $12.5032, valued at $103.8k
06/05/2023 4 Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 6,044 shares @ $11.3596, valued at $68.7k
06/05/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,700 shares @ $11.3626, valued at $132.9k
Exercised 7,125 options to buy @ $2.45, valued at $17.5k
Exercised 4,575 options to buy @ $2.94, valued at $13.5k
05/19/2023 4 SBLENDORIO GLENN (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Exercised 15,000 options to buy @ $3.32, valued at $49.8k
05/17/2023 4 Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 6,044 shares @ $11.1808, valued at $67.6k
05/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 6,044 shares @ $11.2156, valued at $67.8k
04/05/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,700 shares @ $11.2143, valued at $131.2k
Exercised 11,700 options to buy @ $2.45, valued at $28.7k
03/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy